1. Immunology/Inflammation
  2. Glycoprotein VI
  3. 10P3Me

10P3Me 是一种 Glypican-3 (GPC3) 靶向探针,与人源靶点的 Ka 为 93.8 nM。10P3Me 对 GPC3 具有高结合亲和力,能够靶向 GPC3 阳性细胞,用于 PET 成像。10P3Me 在包括皮下异种移植模型和原位 HepG2-LUC 肝癌模型在内的 GPC3 阳性肿瘤组织中选择性聚集,实现病灶的精确定位

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Custom Peptide Synthesis

10P3Me

10P3Me Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

10P3Me is a Glypican-3 (GPC3)-targeting probe with a Ka of 93.8 nM for the human target. 10P3Me exhibits high binding affinity to GPC3, targets GPC3-positive cells, and serves as an agent for PET imaging. 10P3Me selectively accumulates in GPC3-positive tumor tissues, including subcutaneous xenograft models and orthotopic HepG2-LUC liver cancer models, to achieve precise localization of lesions[1].

体外研究
(In Vitro)

10P3Me (1 μCi per well;0.5-4 h) 在 GPC3 高表达的 HepG2、Hep3B2.1−7 和 Huh−7 细胞中的摄取量显著高于 GPC3 低表达的 H1975 细胞[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

10P3Me (200−300 μCi;i.v.) 具有特异性的高肿瘤摄取率,并在 GPC3 高表达的皮下 HCC 异种移植模型中具有较长的滞留时间[1]
10P3Me (150−200 μCi;i.v.) 在 HepG2 异种移植模型中表现出较高的肿瘤峰值摄取量和理想的肿瘤-肝脏比值[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Athymic nude mice (female, 4−6 weeks old, 18−22 g, subcutaneous xenograft hepatocellular carcinoma model)[1]
Dosage: 200−300 μCi
Administration: i.v.; static scans at 60 and 120 min post-injection
Result: Reached peak tumor uptake of 5.62% ID/mL at 1 h and 3.53% ID/mL at 2 h post-injection in HepG2 xenograft models.
Achieved SUVmean of 5.09% ID/mL at 1 h, which was 3.97 times higher than in GPC3-low H1975 models.
Markedly reduced tumor accumulation in blocking groups and H1975 models.
Animal Model: Athymic nude mice (female, 4−6 weeks old, 18−22 g, orthotopic xenograft hepatocellular carcinoma model)[1]
Dosage: 200−300 μCi
Administration: i.v.; PET imaging at 1 h post-injection
Result: Clearly localized intrahepatic tumor lesions in the left hepatic lobe via PET/CT imaging at 1 h post-injection, which was confirmed by surgical dissection.
Animal Model: Athymic nude mice (female, 4−6 weeks old, 18−22 g, subcutaneous xenograft hepatocellular carcinoma model)[1]
Dosage: 150−200 μCi
Administration: i.v.; assessed at 10, 30, 60, 120, and 240 min post-injection
Result: Reached peak tumor uptake of 6.92% ID/g at 30 min post-injection.
Achieved a tumor-to-liver ratio of 8.28 at 60 min post-injection.
分子量

2215.55

Formula

C101H151N23O29S2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
10P3Me
目录号:
HY-P11618
需求量: